openPR Logo
Press release

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain, Current Clinical and Commercial landscape by considering Disease Pathogenesis, Diagnosis, Prognosis and Clinical comparison of Marketed Therapies

10-18-2016 11:42 AM CET | Health & Medicine

Press release from: Researchmoz Global Pvt. Ltd.

Global Diabetes and Obesity Drugs Market to 2022 - Insulins

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment Size and Share Published in 2016-08-01 Available for US$ 4995 at Researchmoz.us

Description

To Browse a Full Report at: http://www.researchmoz.us/global-diabetes-and-obesity-drugs-market-to-2022-insulins-and-gpcrs-retain-commercial-prominence-while-high-unmet-need-remains-in-weight-loss-treatment-report.html

Diabetes is a chronic metabolic disease characterized by hyperglycemia (high blood glucose levels) that results from defects in insulin secretion, insulin action, or both. Chronic hyperglycemia in diabetic patients is associated with long-term damage, dysfunction and failure of multiple organs, including the eyes, kidneys, nerves, heart and blood vessels. The vast majority of diabetes mellitus patients can be classified as having either type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM). Obesity, meanwhile, is defined as abnormal or excessive body fat accumulation that presents a risk to health.

A current global rise in T2DM prevalence is intrinsically linked with the current global rise in obesity. The rapidly increasing global obesity prevalence has resulted in it being considered a global epidemic, and there is a vast and growing global patient population potentially requiring pharmacotherapeutic treatment.

Historically anti-obesity therapeutics have been out of favor due to safety concerns. Both diabetes and obesity products are commonly associated with cardiovascular adverse events, and this is further compounded by concerns relating to cancer development through long-term usage of anti-obesity products. This has resulted in an unmet need for products with favorable safety and efficacy profiles, particularly in the case of obesity.

The market size for the diabetes and obesity disease cluster is set to increase considerably, driven by the success of a number of T2DM pipeline products, and a rapidly expanding global patient population. However, obesity pipeline activity is set to remain markedly low, despite a patient population of epidemic proportions.



Get a Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=799451



Scope

What are the current treatment options for diabetes and obesity?

What are the common molecular targets of pipeline therapies, and how strongly do they overlap with the current market?

Will the pipeline address unmet needs such as a lack of safe treatment options for diabetes and obesity patients?

Which late-stage pipeline products are likely to impact the current market?

How are revenues of key companies, targets and molecule types anticipated to change over the forecast period?

Which companies are anticipated to be the most prominent players over the next seven years?

How do licensing and co-development deals compare between diabetes and obesity?



Reasons To Buy

Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis, including a clinical comparison of marketed therapies.

Visualize the composition of the diabetes and obesity market in terms of the clinical and commercial standing of current dominant therapies. Unmet needs are highlighted to allow a competitive understanding of gaps in the current market.

Analyze the diabetes and obesity pipeline and stratify pipeline therapies by stage of development, molecule type and molecular target. There is a strong contrast in the amount of pipeline activity for diabetes and obesity.

Analyze how individual company, molecule type and molecular target revenues are anticipated to change over the forecast period, highlighting prominent companies and the most promising molecule types and targets.

Identify which companies are the current key players for the disease cluster, and how this pattern is anticipated to change over the forecast period.

Identify commercial opportunities in the diabetes and obesity deals landscape by analyzing trends in licensing and co-development deals by stage of development, molecule type and molecular target.

Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=799451



Table of Content

1 Table of Contents 4

1.1 List of Tables 6

1.2 List of Figures 6

2 Introduction 9

2.1 Therapy Area Introduction 9

2.1.1 Diabetes 9

2.1.2 Obesity 10

2.2 Symptoms 11

2.2.1 Diabetes 11

2.2.2 Obesity 11

2.3 Etiology and Pathophysiology 11

2.3.1 Type 1 Diabetes Mellitus 11

2.3.2 Type 2 Diabetes Mellitus 12

2.3.3 Obesity 12

2.3.4 The Association between Obesity and T2DM 13

2.4 Comorbidities and Complications 13

2.5 Epidemiology Patterns and Forecasts across the 7MM 14

2.5.1 Diabetes 15

2.5.2 Obesity 16

2.6 Treatment 17

2.6.1 Diabetic Pharmacotherapeutics 17

2.6.2 Insulin Therapy 18

2.6.3 Amylin Analogs 19

2.6.4 Obesity Pharmacotherapeutics 20



3 Key Marketed Products 22

3.1 Overview 22

3.2 Diabetes – Top Eight Key Marketed Products 23

3.2.1 Lantus (insulin glargine) – Sanofi 23

3.2.2 Novolog (insulin aspart) – Novo Nordisk 24

3.2.3 Januvia (sitagliptin phosphate) – Merck & Co 25

3.2.4 Levemir (insulin detemir) – Novo Nordisk 26

3.2.5 Victoza (liraglutide) – Novo Nordisk 27

3.2.6 Humalog (insulin lispro) – Eli Lilly 28

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Website @ www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain, Current Clinical and Commercial landscape by considering Disease Pathogenesis, Diagnosis, Prognosis and Clinical comparison of Marketed Therapies here

News-ID: 373385 • Views: 235

More Releases from Researchmoz Global Pvt. Ltd.

Online Fitness Services Market Size, Share, Growth, Trend, Drivers and Restraint …
Online Fitness Services Market is predicted to grow at substantial compounded annual rate of growth (CAGR) during the forecast period 2020-2027. The markets growth is analysed by studying multiple determinants like Market Drivers, Trends, Challenges, Opportunities, Restraints, and Competition. It includes detailed analysis of the market on the basis of competitive profiles of key players, market segmentations, geographical analysis and economic models. The influence of Covid-19 on the market is discussed
Senior Living Market Current Status and Challenges with Future Opportunities to …
The Senior Living Market Report provides a detailed assessment of the market by highlighting information on various aspects including the global market, including drivers, restraints, opportunities, threats and development trends, competitive landscape analysis, and Growth status of key regions. The report provides comprehensive numerical analysis of the Senior Living industry and data for creating strategies to increase market growth and success. The report estimates market size, price, revenue, gross margin
Testing and Inspection Services Market 2020 Analysis includes Growth, Challenges …
The Testing and Inspection Services Market Report provides a detailed assessment of the market by highlighting information on various aspects including the global market, including drivers, restraints, opportunities, threats and development trends, competitive landscape analysis, and Growth status of key regions. The report provides comprehensive numerical analysis of the Testing and Inspection Services industry and data for creating strategies to increase market growth and success. The report estimates market size,
Proctoring Solution for Online Exams Market 2021 Leading Players, Industry Updat …
The study provides an in-depth study of the Proctoring Solution for Online Exams Market's trends and opportunities. On the basis of recent events and historical data, it makes figurative estimates and forecasts the future for the coming years. Moreover, the market document holds a substantial importance when it is about explaining market definition, classifications, applications and engagements. With the study of competitor analysis conducted in this Proctoring Solution for Online

All 5 Releases


More Releases for Diabetes

Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their
Global Diabetes Industry
Global Diabetes Industry Market Insight Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling
Diabetes Drugs Market: Increasing Prevalence of Diabetes to Stoke Market Growth
According to the TMR report, the global diabetes drugs market stood at a valuation of US$43.1 bn in 2016 and is likely to be valued at US$58.4 bn by the end of 2025 expanding at a CAGR of 3.6% between 2017 and 2025. Research and Development Pursuits to Introduce Novel Products Stokes Growth The rising per capita income in several parts of world leading to changing lifestyles and adoption of unhealthy food